Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...
The World Health Organization (WHO) has announced its recommendations for the 2026-2027 Northern Hemisphere influenza vaccine composition, highlighting the continued spread of A(H3N2) subclade K and ...
Gene therapy offers significant opportunities globally due to its potential in treating genetic disorders. Current strategies involve modified viral vectors for gene delivery, with applications in ...
February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...
The morning tape is leaning decisively toward defense-linked manufacturers, advanced materials innovators, and capital-raising energy names, as fresh contract wins and strategic investments reinforce ...
Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...
Gordian Biotechnology, a biotechnology company focused on discovering and validating therapeutic targets through causal biology, today announced the release of a new preprint, titled: "A Multispecies, ...
Deep mutational scanning reveals pharmacologically relevant insights into TYK2 signaling and disease
This important paper presents a rigorous and comprehensive deep mutational analysis of the kinase TYK2, revealing how single amino acid substitutions influence protein abundance, signaling activity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results